Dette indikerer, at raske forsøgspersoner er repræsentative for den farmakokinetiske/ farmakodynamiske vurdering i patientpopulationen med arthritis urica.
In general, febuxostat pharmacokinetic parameters estimated by these analyses are consistent with those obtained from healthy subjects, indicating that healthy subjects are representative for pharmacokinetic/ pharmacodynamic assessment in the patient population with gout.